Dr. Chronos trained as an Interventional Cardiologist in London. He received a Bachelor’s degree in medicine and surgery from the Royal Free Hospital School of Medicine at the University of London in 1987. He then trained in cardiology and interventional cardiology at the Royal Brompton National Heart and Lung Institute in London. In 1992, Dr. Chronos was awarded a British Heart Foundation International Fellowship and moved to the United States to continue his research in interventional cardiology at Emory University School of Medicine under the direction of Dr. Spencer B. King, III. Known for his pioneering research in angiogenesis, he was named Co-National Principal Investigator on the FIRSTstudy, the largest human clinical trial of angiogenesis. Dr. Chronos has been an advisor and member of the National Institute of Health SBIR medical device advisory panel and has had numerous appointments to advisory boards of both industry and the American college of cardiology.
Dr. Chronos’ career spans industry and academia. He was named Director of Research at the Andreas Gruentzig Cardiovascular Center at Emory University Hospital in 1997. Dr. Chronos joined Atlanta Cardiology Group in 1999 where he developed and served as CEO of the Saint Joseph’s Translational Research Institute until 2012 when he left to form Cardiology Care Clinics. He is currently the President and COO of Vicapsys a company founded on intellectual property developed at MGH. Dr. Chronos has also served as an adjunct Partner at Essex Woodlands Health Ventures and has held Academic and faculty appointments at Duke and Stanford Universities as a Consulting Professor of Medicine and Cardiology. He is a Fellow of the American College of Cardiology, the European Society of Cardiology and the Royal College of Physicians of London. He has published several books and more than 200 peer-reviewed articles.